Abstract
A novel series of pyrrole inhibitors of MEK kinase has been developed using structure-based drug design. Optimization of the series led to the identification of potent inhibitors with good pharmaceutical properties.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have